Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-15-004798
Filing Date
2015-06-15
Accepted
2015-06-15 14:17:20
Documents
5
Period of Report
2015-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp57102_6k.htm 6-K 14460
2 EXHIBIT 99.1 dp57102_ex9901.htm EX-99.1 6771
3 EXHIBIT 99.2 dp57102_ex9902.htm EX-99.2 16536
4 EXHIBIT 99.3 dp57102_ex9903.htm EX-99.3 18830
5 EXHIBIT 99.4 dp57102_ex9904.htm EX-99.4 7872
  Complete submission text file 0000950103-15-004798.txt   65436
Mailing Address JOUKAHAISENKATU 6 TURKU H9 FI-20520
Business Address JOUKAHAISENKATU 6 TURKU H9 FI-20520 358-2-274-8900
Biotie Therapies Corp. (Filer) CIK: 0001579695 (see all company filings)

EIN.: 000000000 | State of Incorp.: H9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37423 | Film No.: 15930910
SIC: 2834 Pharmaceutical Preparations